PAHC
PHIBRO ANIMAL HEALTH CORPPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 30 to Mar 31 ▼ 2 days of insider sells: $756.8K by 1 insider, avg $53.75
- Apr 14 to May 7 ▼ 12 days of insider sells: $4.5M by 1 insider, avg $55.05
- Apr 15 Citigroup initiates
- May 6 ▲ Phibro Animal Health reported Q3 FY2026 results with net sales of $3…
- May 29 ▲ 1 insider buy $317.7K at $31.77
- Nov 4 ▼ Earnings: PAHC Q1 2027 Earnings: EPS $0.79 (-2.6% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $317.7K at an average $31.77. 1 insider sold $5.3M. Price is 10% above their cost.
- InstitutionsBULLISH
Q3 2026: 23 added (1 new), 9 trimmed or exited. Largest new: Boston Partners $10.9M.
- Short sellersSTEADY
Short interest −1.3% to 1.02M shares. 6.4 days to cover, ≈2.5% of shares.
- TrendDOWNTREND
5% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Boston Partners | NEW | $10.9M |
| Invesco Ltd. | TRIM | $5.4M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $3.5M |
| MARSHALL WACE, LLP | DOUBLED | $3.4M |
| Quantinno Capital Management LP | ADD | $1.3M |
| Neuberger Berman Group LLC | ADD | $1.1M |
| Quadrature Capital Ltd | DOUBLED | $636.3K |
| VANGUARD ASSET MANAGEMENT, Ltd | ADD | $612.6K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action May 2026Price is below the lowest target. Median implies +40%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| May 14, 2026 | Citigroup MAINTAIN | Neutral |
| Apr 15, 2026 | Citigroup INITIATE | Neutral |
| Nov 7, 2025 | JP Morgan MAINTAIN | Overweight |
| Aug 29, 2025 | B of A Securities MAINTAIN | Underperform |
| Jul 7, 2025 | JP Morgan UPGRADE | Overweight |
| Jun 25, 2025 | Morgan Stanley MAINTAIN | Equal-Weight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
David Glenn Chief Financial Officer Aug 6, 2026 | AWARD | 3,482 sh |
Miller Larry Lee Chief Operating Officer Aug 6, 2026 | AWARD | 3,726 sh |
Bendheim Daniel M President and CEO Aug 6, 2026 | AWARD | 11,699 sh |
BENDHEIM JACK Executive Chairman Aug 6, 2026 | AWARD | 12,103 sh |
Miller Larry Lee Chief Operating Officer Aug 6, 2026 | AWARD | 3,522 sh |
Escudero Lisa Ann See Remarks Aug 6, 2026 | AWARD | 1,547 sh |
Weinstein Judith See Remarks Aug 6, 2026 | AWARD | 2,478 sh |
David Glenn Chief Financial Officer Aug 6, 2026 | AWARD | 3,334 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | $0.87 | $0.84–$0.89 | +2.0% | $397.0M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
9 filings · 1 bullish · 2 bearish · 6 neutral- NEUTRAL 8-KNov 4, 2026
Phibro Animal Health reported Q1 FY2027 net sales of $386.8M (+6% YoY) and GAAP diluted EPS of…
The EPS miss relative to consensus, combined with flat adjusted gross margin and rising SG&A, tempers the positive revenue beat. Watch for progress on Brazilian virginiamycin regulatory approvals…
- NEUTRAL 8-KNov 3, 2026
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its…
Dividend unchanged at $0.12/quarter; monitor next earnings release for any change in payout policy or financial performance.
- BEARISH SC 13G/AOct 19, 2026
Millennium Management LLC filed an amended Schedule 13G disclosing a passive 3.9% stake in Phibro…
Monitor for further selling by Millennium or other large holders. The reduction below 5% removes disclosure requirements for future sales, potentially leading to additional unwinding without public…
- NEUTRAL 8-KJul 28, 2026
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its…
Dividend declaration is routine and provides no new information on business performance or outlook. Monitor the next quarterly earnings release for any changes to the dividend policy or fundamental…
All PAHC filing & press-release reports (9)
- 8-K reportNov 4, 2026
- 8-K reportNov 3, 2026
- SC 13G/A reportOct 19, 2026
- 8-K reportJul 28, 2026
- 8-K reportJun 26, 2026
- 8-K reportMay 6, 2026
- 8-K reportMay 5, 2026
- 8-K reportApr 30, 2026
- 8-K reportApr 27, 2026